68083-412 : Cangrelor 50 mg Intravenous Injection, Powder, Lyophilized, for Solution
| NDC: | 68083-412 |
| Labeler: | Gland Pharma Limited |
| Product Type: | Human Prescription Drug |
| Drug Name: | Cangrelor |
| Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
| Application #: | ANDA213551 |
| Rev. Date: |
NDC Package Codes:
- 68083-412-10: 10 VIAL, SINGLE‑DOSE IN 1 CARTON (68083‑412‑10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Cangrelor
Dosage Strength:
- 50 mg
Pharmaceutical Classes:
- Decreased Platelet Aggregation [PE]
- P2Y12 Platelet Inhibitor [EPC]
- P2Y12 Receptor Antagonists [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 68083-411Next: 68083-414 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.